Resources

In part 5 of this Exclusive Interview, Dr. Ronald Swerdloff talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the possibility of testosterone therapy for the person with sexual dysfunction.

In part 6 of this Exclusive Interview, Dr. Ronald Swerdloff talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the key takeaways from his presentation.

In part 7, the conclusion of this Exclusive Interview, Dr. Ronald Swerdloff talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about ways to naturally increase testosterone.

This Disaster Averted is not just about one patient but about many who take insulin. Most think high A1C means one needs to increase insulin. Not always! Remember, A1C is an average. Just because someone has an A1C of <7% doesn't actually mean glucose is managed.

In part 6 of this Exclusive Interview, Dr. Ray Kausik talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 convention in San Diego, CA about the impact of treatments in an ongoing effort to lower cholesterol.

In this week's Homerun Slides, the old versus the new understanding about the cause of common diabetes complications.

Obesity is a global epidemic that has far-reaching economic and public health implications. Excess body weight is associated with multiple comorbidities including type 2 diabetes (T2DM), hypertension, obstructive sleep apnea (OSA), and cardiovascular disease (CVD). Dysglycemia andOSA share common risk factors such as age and obesity; hence it is not surprising that OSA and glycemic abnormalities often coexist.

Part 4: Using Computers to Determine Type 2 Treatment: The first three articles in this series focused on what makes treating type 2 diabetes so difficult: the overwhelming number of medicines and combinations; finding effective treatments that work with our patients' insurance coverage and household budgets; and incorporating factors beyond glucose control, such as body weight, adherence, and side effects, into our decisions. In this installment, we discuss how those problems can be represented in ways that computers can understand.

Does adding Zetia to a multifaceted drug therapy regimen help improve health outcomes?

A closer look into what’s new according to the WHO shows if more women are at risk for gestational diabetes than thought.